Univariate analysis | ||
Variable | β | p Value |
Clinical | ||
Age | −0.16 | 0.3 |
Gender | −0.10 | 0.4 |
Body surface area | −0.20 | 0.2 |
Hypertension | −0.002 | 0.9 |
β Blockers | −0.09 | 0.5 |
Calcium channel blockers | −0.1 | 0.4 |
New York Heart Association class | −0.1 | 0.5 |
Resting heart rate | −0.06 | 0.7 |
Resting systolic blood pressure | −0.004 | 0.9 |
Resting diastolic blood pressure | 0.017 | 0.9 |
Echocardiography | ||
Deceleration time | 0.16 | 0.3 |
E/E′ ratio | −0.08 | 0.7 |
Myocardial performance index | 0.03 | 0.9 |
LV end-diastolic stiffness | −0.20 | 0.4 |
Resting peak LVOT gradient | −0.11 | 0.5 |
Provokable (pre-stress) peak LVOT gradient (amyl nitrite or Valsalva) | −0.12 | 0.5 |
Post stress peak LVOT gradient | −0.20 | 0.4 |
Resting mitral regurgitation | −0.06 | 0.7 |
Post-stress mitral regurgitation | −0.06 | 0.7 |
Cardiac magnetic resonance | ||
Basal end-diastolic interventricular septal thickness | −0.2 | 0.2 |
Left atrial area index | −0.17 | 0.3 |
Left ventricular end-systolic index | 0.18 | 0.3 |
Left ventricular end-diastolic index | 0.1 | 0.5 |
Left ventricular ejection fraction | −0.05 | 0.8 |
Left ventricular mass index | −0.09 | 0.6 |
Degree of delayed hyperenhancement | −0.16 | 0.3 |
Ascending aortic distensibility | 0.31 | 0.03 |
Pulse wave velocity | −0.32 | 0.03 |
Because aortic stiffness was the only significant variable, multivariable analysis was not performed.
LVOT, left ventricular outflow tract.